4 reported observational data from Shanghai Sixth Peoples Hospital, China, showing that, with adequate treatment duration, GLP-1 agonists may have disease-modifying effects in patients with KOA with comorbid Type 2 diabetes, potentially mediated by weight loss
Social media clips and discussion forums may surface news quickly, but they can also blur the difference between trial data, regulatory approval, and market access
It would be nice to see more detailed research about how these medications might actually be helping Alzheimers patients, he continued
The amount of cytokine was normalized to the DNA content, and the normalized datasets were subjected to statistical analysis
Ngh s Thanh T, hu Huyn My,